Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors

Ann Rheum Dis. 2022 Apr;81(4):592-593. doi: 10.1136/annrheumdis-2021-221607. Epub 2021 Nov 29.
No abstract available

Keywords: COVID-19; arthritis; juvenile; tumor necrosis factor inhibitors; vaccination.

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / immunology*
  • Arthritis, Juvenile / drug therapy
  • Arthritis, Juvenile / immunology*
  • Arthritis, Juvenile / virology
  • COVID-19 / prevention & control
  • COVID-19 Vaccines / immunology*
  • Female
  • Humans
  • Immunogenicity, Vaccine / drug effects*
  • Male
  • SARS-CoV-2 / immunology
  • Tumor Necrosis Factor Inhibitors / adverse effects
  • Tumor Necrosis Factor Inhibitors / immunology*
  • Vaccines, Synthetic / immunology*
  • Young Adult
  • mRNA Vaccines / immunology*

Substances

  • Antirheumatic Agents
  • COVID-19 Vaccines
  • Tumor Necrosis Factor Inhibitors
  • Vaccines, Synthetic
  • mRNA Vaccines